Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

Kantarjian H, O'Brien S, Ravandi F, Cortes J, Shan J, Bennett JM, List A, Fenaux P, Sanz G, Issa JP, Freireich EJ, Garcia-Manero G.

Cancer. 2008 Sep 15;113(6):1351-61. doi: 10.1002/cncr.23697.

PMID:
18618511
[PubMed - indexed for MEDLINE]
Free Article
2.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
[PubMed - indexed for MEDLINE]
3.

Evaluating the prognosis of patients with myelodysplastic syndromes.

Aul C, Giagounidis A, Germing U, Ganser A.

Ann Hematol. 2002 Sep;81(9):485-97. Epub 2002 Sep 24. Review.

PMID:
12373348
[PubMed - indexed for MEDLINE]
4.

[Myelodysplastic syndromes. Diagnosis and therapeutic strategies].

Aul C, Giagounidis A, Germing U, Ganser A.

Med Klin (Munich). 2002 Nov 15;97(11):666-76. Review. German.

PMID:
12434275
[PubMed - indexed for MEDLINE]
5.

Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management.

Garcia-Manero G.

Am J Hematol. 2012 Jul;87(7):692-701. doi: 10.1002/ajh.23264. Review.

PMID:
22696212
[PubMed - indexed for MEDLINE]
6.

Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia.

Matsushima T, Handa H, Yokohama A, Nagasaki J, Koiso H, Kin Y, Tanaka Y, Sakura T, Tsukamoto N, Karasawa M, Itoh K, Hirabayashi H, Sawamura M, Shinonome S, Shimano S, Miyawaki S, Nojima Y, Murakami H.

Blood. 2003 May 1;101(9):3386-90. Epub 2002 Dec 27. Review.

PMID:
12506028
[PubMed - indexed for MEDLINE]
Free Article
7.

Prognostic factors and scoring systems in myelodysplastic syndromes.

Sanz GF, Sanz MA, Greenberg PL.

Haematologica. 1998 Apr;83(4):358-68. Review.

PMID:
9592987
[PubMed - indexed for MEDLINE]
Free Article
8.

The search for better prognostic models in myelodysplastic syndromes.

Santos FP, Kantarjian H, Garcia-Manero G, Ravandi F.

Curr Hematol Malig Rep. 2011 Mar;6(1):13-21. doi: 10.1007/s11899-010-0070-x. Review.

PMID:
21136214
[PubMed - indexed for MEDLINE]
9.

Cytogenetic features in myelodysplastic syndromes.

Haase D.

Ann Hematol. 2008 Jul;87(7):515-26. doi: 10.1007/s00277-008-0483-y. Epub 2008 Apr 15. Review.

PMID:
18414863
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The lower risk MDS patient at risk of rapid progression.

Mittelman M, Oster HS, Hoffman M, Neumann D.

Leuk Res. 2010 Dec;34(12):1551-5. doi: 10.1016/j.leukres.2010.05.023. Epub 2010 Jun 22. Review.

PMID:
20573398
[PubMed - indexed for MEDLINE]
11.

Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.

Horiike S, Kita-Sasai Y, Nakao M, Taniwaki M.

Leuk Lymphoma. 2003 Jun;44(6):915-22. Review.

PMID:
12854888
[PubMed - indexed for MEDLINE]
12.

Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.

Beran M.

Int J Hematol. 2000 Aug;72(2):139-50. Review.

PMID:
11039661
[PubMed - indexed for MEDLINE]
13.

Prognostic scoring systems for risk assessment in myelodysplastic syndromes.

Greenberg PL, Sanz GF, Sanz MA.

Forum (Genova). 1999 Jan-Mar;9(1):17-31. Review.

PMID:
10101208
[PubMed - indexed for MEDLINE]
14.

Risk factors and their relationship to prognosis in myelodysplastic syndromes.

Greenberg PL.

Leuk Res. 1998 May;22 Suppl 1:S3-6. Review.

PMID:
9734692
[PubMed - indexed for MEDLINE]
15.

A comparative review of classification systems in myelodysplastic syndromes (MDS).

Bennett JM.

Semin Oncol. 2005 Aug;32(4 Suppl 5):S3-10. Review.

PMID:
16085011
[PubMed - indexed for MEDLINE]
16.

Prognosis of myelodysplastic syndromes.

Garcia-Manero G.

Hematology Am Soc Hematol Educ Program. 2010;2010:330-7. doi: 10.1182/asheducation-2010.1.330. Review.

PMID:
21239815
[PubMed - indexed for MEDLINE]
Free Article
17.

Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.

Garcia-Manero G.

Am J Hematol. 2011 Jun;86(6):490-8. doi: 10.1002/ajh.22047. Review.

PMID:
21594886
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk